106P Impact of molecular alterations in advanced biliary tract cancer (BTC) patients (pts) treated with cisplatin, gemcitabine, durvalumab (CGD): A large global studyF. Lo Prinzi, A. Casadei Gardini, Lorenzo Fornaro et al.|ESMO Open|2025Cited by 0